A new research paper was published in Oncotarget (Volume 16) on November 6, 2025, titled "LRIG1-3 in gliomas: LRIG1 protein expression decreased in higher grade gliomas." In this study by Marlene ...

Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for ...

These tumors are less likely to spread to surrounding tissues than higher-grade tumors, so they often have better outcomes. In the past, pediatric gliomas were classified into low-grade and high-grade ...

IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young ...

New research reveals that certain brain tumors may originate silently within normal brain cells long before a tumor forms.

“Our results reinforce suggestions that LRIG1-3 could function as diagnostic markers and therapeutic targets in the treatment of gliomas” “Our results reinforce suggestions that LRIG1-3 could function ...

The genes encoding IDH1/2 and BRAF are frequently altered in low-grade glioma; the presence or absence of these alterations should be determined in all patients. Maximal safe tumor resection remains ...

Researchers at the UNC School of Medicine and the UNC Eshelman School of Pharmacy have made a breakthrough that could modernize treatment for glioblastoma, a fast-growing and deadly form of brain ...

Researchers are developing and testing new treatments for isocitrate dehydrogenase (IDH)-mutant gliomas, including targeted therapies and immunotherapies. These treatments may help improve survival ...